Influence of rate of heating on thermosensitivity of L1210 leukemia: membrane lipids and Mr 70,000 heat shock protein.

Abstract:

:We examined the effect of rate of temperature rise on the thermosensitivity of a murine lymphoblastic leukemia. L1210 cells suspended in RPMI 1630 medium:5% fetal bovine serum at pH 7.4 were heated from 37 degrees C-42 degrees C, or 44 degrees C over variable times (immediately, 30, 60, 120, 180 min) in a circulating water bath controlled by an electronic temperature programmer. Survival of the cells using a soft agar clonogenic assay was plotted against the time at final temperature so that a Do (min of heat required to reduce survival by 63% on the exponential portion of the survival curve) could be calculated as an estimate of thermosensitivity. Cells heated from 37 degrees C-42 degrees C over a time period of 30 min (10 degrees C/h) were less thermosensitive (Do 62.7 +/- 12.5 min) as compared to those exposed immediately to 42 degrees C (Do 38.5 +/- 2.2 min). Cells heated over a period of 180 min (1.6 degrees C/h) showed almost no death even after 4 h at 42 degrees C. Thermosensitivity of cells heated to several other high temperatures was also a function of rate of heating. This relative thermal resistance induced by slow heating was not a result of a change in membrane cholesterol content or fatty acid composition. Similarly, there was no difference between cells heated at slow and fast rates in cell cycle distribution or in cellular protein concentration. The major heat shock protein of Mr 70,000, which was induced by immediate heating, was not synthesized at the same high rate 1-12 h after heat treatment by the cells made thermotolerant with slow heating. We conclude that the thermosensitivity of this neoplastic cell can be altered considerably by the rate of heating. This alteration is not due to a change in membrane lipids. Furthermore, the heat shock protein at Mr 70,000 which was synthesized after immediate heating could not be demonstrated in the gradually heated L1210 leukemia cells.

journal_name

Cancer Res

journal_title

Cancer research

authors

Burns CP,Lambert BJ,Haugstad BN,Guffy MM

subject

Has Abstract

pub_date

1986-04-01 00:00:00

pages

1882-7

issue

4 Pt 1

eissn

0008-5472

issn

1538-7445

journal_volume

46

pub_type

杂志文章
  • Enhancement of X-ray cell killing in cultured mammalian cells by the protein phosphatase inhibitor calyculin A.

    abstract::Effects of calyculin A, a potent inhibitor of protein phosphatases 1 and 2A, on X-ray cell killing and chromatin structure were studied using cultured mammalian cells (BHK21). Calyculin A at concentrations of 2.5-20 nM enhanced X-ray cell killing when exponentially growing BHK21 cells were treated with calyculin A for...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nakamura K,Antoku S

    更新日期:1994-04-15 00:00:00

  • Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma.

    abstract::The mechanisms which control estrogen receptor (ER) expression in breast carcinoma have not been elucidated. The MCF-7 (ER-positive) and MDA-MB-231 (ER-negative) breast carcinoma cell lines have been used to examine ER gene expression. Northern blot analysis of mRNA isolated from these two cell lines demonstrates that...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weigel RJ,deConinck EC

    更新日期:1993-08-01 00:00:00

  • Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer.

    abstract::In our previous studies we showed that motility related protein 1 (MRP-1) is a glycoprotein recognized by mAb M31-15, and that the sequence of MRP-1 is identical to that of CD9, a WBC differentiation antigen. Transfection of MRP-1/CD9 cDNA into cultured nonhematopoietic cells suppresses cell motility. The extent of su...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Miyake M,Nakano K,Ieki Y,Adachi M,Huang CL,Itoi S,Koh T,Taki T

    更新日期:1995-09-15 00:00:00

  • Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.

    abstract::TP53 is the most frequently altered gene in head and neck squamous cell carcinoma (HNSCC), with mutations occurring in over two thirds of cases; however, the predictive response of these mutations to cisplatin-based therapy remains elusive. In the current study, we evaluate the ability of the Evolutionary Action score...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2729

    authors: Osman AA,Neskey DM,Katsonis P,Patel AA,Ward AM,Hsu TK,Hicks SC,McDonald TO,Ow TJ,Alves MO,Pickering CR,Skinner HD,Zhao M,Sturgis EM,Kies MS,El-Naggar A,Perrone F,Licitra L,Bossi P,Kimmel M,Frederick MJ,Lichtarge

    更新日期:2015-04-01 00:00:00

  • DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer.

    abstract::DNA methylation patterns are established and maintained by three DNA methyltransferases (DNMT): DNMT1, DNMT3A, and DNMT3B. Although essential for development, methylation patterns are frequently disrupted in cancer and contribute directly to carcinogenesis. Recent studies linking polycomb group repression complexes (P...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0116

    authors: Jin B,Yao B,Li JL,Fields CR,Delmas AL,Liu C,Robertson KD

    更新日期:2009-09-15 00:00:00

  • Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.

    abstract::The ability to induce pluripotent stem cells from committed, somatic human cells provides tremendous potential for regenerative medicine. However, there is a defined neoplastic potential inherent to such reprogramming that must be understood and may provide a model for understanding key events in tumorigenesis. Using ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1361

    authors: Ohm JE,Mali P,Van Neste L,Berman DM,Liang L,Pandiyan K,Briggs KJ,Zhang W,Argani P,Simons B,Yu W,Matsui W,Van Criekinge W,Rassool FV,Zambidis E,Schuebel KE,Cope L,Yen J,Mohammad HP,Cheng L,Baylin SB

    更新日期:2010-10-01 00:00:00

  • Chemical synthesis of radiolabeled bleomycin A2 and its binding to DNA.

    abstract::A method for the preparation of biologically active [3H]- and [13C]bleomycin A2 is described. Demethyl Cu(II):bleomycin A2, isolated after pyrolysis of Cu(II):bleomycin A2, was methylated with either [3H]-or [13C]methyl iodide, which resulted in Cu(II):bleomycin A2 labeled in the dimethylsulfonium moiety. Copper was r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Roy SN,Orr GA,Brewer CF,Horwitz SB

    更新日期:1981-11-01 00:00:00

  • Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.

    abstract::Tumor metastasis is one of the most important clinical aspects of neoplastic disease because patient mortality is frequently attributable to disseminated rather than primary tumors. However, it still is not possible to definitively distinguish those individuals at high risk for disseminated disease, who would benefit ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hunter KW,Broman KW,Voyer TL,Lukes L,Cozma D,Debies MT,Rouse J,Welch DR

    更新日期:2001-12-15 00:00:00

  • Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.

    abstract::Previous studies from our laboratories have shown that carcinogenic peroxisome proliferators significantly increase the mRNA levels of peroxisomal beta-oxidation genes in the rat liver by enhancing the transcriptional activity. Because of a good correlation between the inducibility of peroxisome proliferation and carc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nemali MR,Usuda N,Reddy MK,Oyasu K,Hashimoto T,Osumi T,Rao MS,Reddy JK

    更新日期:1988-09-15 00:00:00

  • Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice.

    abstract::Tumor endothelial marker 8 (TEM8) is a recently described protein that is preferentially expressed within tumor endothelium. We have developed a fusion protein that targets TEM8 and disrupts tumor vasculature by promoting localized thrombosis. Fusion protein specificity and function were evaluated using Western blot a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0725

    authors: Fernando S,Fletcher BS

    更新日期:2009-06-15 00:00:00

  • Eosinophils, tissue eosinophilia, and eosinophil-derived transforming growth factor alpha in hamster oral carcinogenesis.

    abstract::Eosinophilia in tissues and/or circulating blood is known to be associated with a wide variety of malignancies but the role of the eosinophil in neoplastic conditions is not known. Using the cheek pouch of the Syrian hamster as an experimental model for oral carcinogenesis, it has recently been shown that eosinophils ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ghiabi M,Gallagher GT,Wong DT

    更新日期:1992-01-15 00:00:00

  • Tetracycline antibiotics impair mitochondrial function and its experimental use confounds research.

    abstract::Tetracyclines, a class of antibiotics that target bacterial translation, are commonly used in research for inducible gene expression using Tet-ON/Tet-OFF systems. However, such tetracycline-inducible systems carry a risk. Given that mitochondria have a "bacterial" ancestry, these antibiotics also target mitochondrial ...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-15-1626

    authors: Chatzispyrou IA,Held NM,Mouchiroud L,Auwerx J,Houtkooper RH

    更新日期:2015-11-01 00:00:00

  • Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats.

    abstract::A dose-response study in carcinogenesis was carried out with N-nitrosomorpholine in female F344 rats. The compound was administered in drinking water, which was supplied in controlled amounts of 20 ml per day per rat, 5 days a wk. At the two highest dose rates, 100 mg/liter and 40 mg/liter, treatment lasted 25 and 40 ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lijinsky W,Kovatch RM,Riggs CW,Walters PT

    更新日期:1988-04-15 00:00:00

  • IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia.

    abstract::IFN regulatory factor 8 (IRF8) is a key transcription factor for myeloid cell differentiation and its expression is frequently lost in hematopoietic cells of human myeloid leukemia patients. IRF8-deficient mice exhibit uncontrolled clonal expansion of undifferentiated myeloid cells that can progress to a fatal blast c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2493

    authors: Hu X,Yang D,Zimmerman M,Liu F,Yang J,Kannan S,Burchert A,Szulc Z,Bielawska A,Ozato K,Bhalla K,Liu K

    更新日期:2011-04-15 00:00:00

  • Positive correlation between calmodulin content and hepatoma growth rates.

    abstract::Calmodulin contents of normal rat liver, host liver [bearing hepatoma 5123t.c.(h)], regenerating liver, and Morris hepatomas 7800, 5123t.c.(h), and 7794A were determined by phosphodiesterase assay and by radioimmunoassay. The calmodulin levels determined by both assays were significantly increased in three hepatomas w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wei JW,Morris HP,Hickie RA

    更新日期:1982-07-01 00:00:00

  • Transfer RNA methylase activity and capacity during aflatoxin B1-induced hepatocellular carcinogenesis.

    abstract::Transfer RNA methylase (tRNA methylase) activity and capacity were monitored in whole-rat-liver preparations during the induction of hepatocellular carcinomas by an 8-week aflatoxin B1 dosing regimen that produced minimal toxic effects. Significant phases of elevated tRNA methylase capacity occurred at 6 to 9 weeks (2...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Busby WF Jr,Paglialunga S,Newberne PM,Wogan GN

    更新日期:1976-06-01 00:00:00

  • Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

    abstract::The interleukin (IL)-13 receptor alpha2 (IL-13Ralpha2) chain is a primary binding and internalization subunit for a Th2-derived immune regulatory cytokine, IL-13. Although extremely high levels of IL-13Ralpha2 chain are expressed on a variety of human tumor cells and specimens, its precise role in tumor immunology has...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1265

    authors: Kawakami K,Terabe M,Kawakami M,Berzofsky JA,Puri RK

    更新日期:2006-04-15 00:00:00

  • Aberrant mitochondria in two human colon carcinoma cell lines.

    abstract::Electron micrographs of CCL237 and FET cells (two slowly growing, differentiated human colon carcinoma lines) revealed enlarged mitochondria with few cristae. Polarographic measurement of respiratory activity in mitochondria isolated from these cell lines was compared to that of CV-1 cells (a normal monkey kidney epit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Modica-Napolitano JS,Steele GD Jr,Chen LB

    更新日期:1989-06-15 00:00:00

  • Immunohistochemical staining of human spermidine/spermine N1-acetyltransferase superinduced in response to treatment with antitumor polyamine analogues.

    abstract::A superinduction of the polyamine catabolic enzyme, spermidine/spermine N1-acetyltransferase (SSAT) accompanies the phenotype-specific cytotoxic response to a class of antitumor polyamine analogues in several important human solid tumor models. A highly specific antiserum against the human SSAT protein has been develo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Casero RA Jr,Gabrielson EW,Pegg AE

    更新日期:1994-08-01 00:00:00

  • Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma.

    abstract::Malignant pleural mesothelioma (MPM) is an aggressive malignant tumor that secretes various angiogenic factors. The main inhibitor of plasminogen activators, PAI-1 (SERPINE1), has been implicated in tumor progression and angiogenesis, and high PAI-1 expression has been associated with poor prognosis in MPM patients. I...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-1796

    authors: Takayama Y,Hattori N,Hamada H,Masuda T,Omori K,Akita S,Iwamoto H,Fujitaka K,Kohno N

    更新日期:2016-06-01 00:00:00

  • Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients.

    abstract::Although radiotherapy (RT) decreases the incidence of locoregional recurrence in breast cancer, patients with triple-negative breast cancer (TNBC) have increased risk of local recurrence following breast-conserving therapy. The relationship between RT and local recurrence is unknown. Here, we tested the hypothesis tha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3623

    authors: Rafat M,Aguilera TA,Vilalta M,Bronsart LL,Soto LA,von Eyben R,Golla MA,Ahrari Y,Melemenidis S,Afghahi A,Jenkins MJ,Kurian AW,Horst KC,Giaccia AJ,Graves EE

    更新日期:2018-08-01 00:00:00

  • Modulation of human lymphocyte O6-alkylguanine-DNA alkyltransferase by streptozotocin in vivo.

    abstract::The ability to modulate DNA repair has been proposed as an effective method to overcome cytotoxic drug resistance in human tumors. However, no studies have shown that it is possible to achieve modulation of DNA repair in humans in vivo. This study analyzes modulation of O6-alkylguanine-DNA alkyltransferase, a DNA repa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gerson SL

    更新日期:1989-06-01 00:00:00

  • Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells.

    abstract::Many but not all of the cell surface antigens studied were released into tissue culture medium of human colorectal carcinoma and melanoma cells maintained in vitro. Two groups of monoclonal antibody-defined antigens are described. One group is composed of molecules that are released easily and in large quantitites int...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Steplewski Z,Chang TH,Herlyn M,Koprowski H

    更新日期:1981-07-01 00:00:00

  • A clinical evaluation of serum C3DP levels in individuals with malignant diseases.

    abstract::A human serum DNA-binding protein (C3DP) derived from complement component C3 has been found in elevated concentrations in the sera of individuals with malignant diseases. An assay system has been devised which reveals quantitative values of serum C3DP levels. Results obtained using this system indicate that normal hu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Parsons RG,Longmire RL,Hoch SO,Hoch JA

    更新日期:1977-03-01 00:00:00

  • Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response.

    abstract::MdmX and Mdm2 regulate p53 tumor suppressor functions by controlling p53 transcriptional activity and/or stability in cells exposed to DNA damage. Accumulating evidence indicates that ATM-mediated phosphorylation and degradation of Mdm2 and MdmX may be the initial driving force that induces p53 activity during the ear...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0634

    authors: Zhang X,Lin L,Guo H,Yang J,Jones SN,Jochemsen A,Lu X

    更新日期:2009-10-15 00:00:00

  • Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).

    abstract::Between February 1987 and July 1988, 45 patients with advanced refractory cancer were treated with LY186641, a diarylsulfonylurea that has shown a broad spectrum of activity in preclinical testing. Patients received a weekly p.o. dose of LY186641 for 6 consecutive weeks; responding and stable patients continued weekly...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hainsworth JD,Hande KR,Satterlee WG,Kuttesch J,Johnson DH,Grindey G,Jackson LE,Greco FA

    更新日期:1989-09-15 00:00:00

  • Comparison of the structural and cytotoxic activity of novel 2,5-bis(carboethoxyamino)-3,6-diaziridinyl-1,4-benzoquinone analogues.

    abstract::Eight analogues of 2,5-bis(carboethoxyamino)-3,6-diaziridinyl-1,4-benzoquinone have been synthesized and tested for cytotoxicity against four different leukemic and lymphomic cell lines. For K562 and BSM cells, the toxicity could be correlated with the ease of reduction of the compounds as determined by the one-electr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dzielendziak A,Butler J,Hoey BM,Lea JS,Ward TH

    更新日期:1990-04-01 00:00:00

  • The DNA N-glycosylase MED1 exhibits preference for halogenated pyrimidines and is involved in the cytotoxicity of 5-iododeoxyuridine.

    abstract::The base excision repair protein MED1 (also known as MBD4), an interactor with the mismatch repair protein MLH1, has a central role in the maintenance of genomic stability with dual functions in DNA damage response and repair. MED1 acts as a thymine and uracil DNA N-glycosylase on T:G and U:G mismatches that occur at ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4488

    authors: Turner DP,Cortellino S,Schupp JE,Caretti E,Loh T,Kinsella TJ,Bellacosa A

    更新日期:2006-08-01 00:00:00

  • Plasma pharmacokinetics of high-dose oral melphalan in patients treated with trialkylator chemotherapy and autologous bone marrow reinfusion.

    abstract::The pharmacokinetics of melphalan following high-dose p.o. administration were determined in 17 patients with various malignancies for the purpose of assessing interpatient and intrapatient pharmacokinetic variability. All patients underwent bone marrow harvest on day -8 (relative to bone marrow reinfusion). On days -...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Choi KE,Ratain MJ,Williams SF,Golick JA,Beschorner JC,Fullem LJ,Bitran JD

    更新日期:1989-03-01 00:00:00

  • Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells.

    abstract::Loss of function of the tumor suppressor protein p53 represents a very frequent event in human carcinogenesis, but the molecular mechanisms linking impaired p53 activity to increased cell malignancy are still incompletely understood. p53 is normally involved in both cell cycle control and the induction of cell death a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pani G,Bedogni B,Anzevino R,Colavitti R,Palazzotti B,Borrello S,Galeotti T

    更新日期:2000-08-15 00:00:00